中文名 | NCH-51 |
英文名 | PTACH |
别名 | 化合物PTACH |
英文别名 | PTACH NCH 51 NCH-51 PTACH (NCH-51) HDAC Inhibitor XXII, NCH51 Cpd 51, S-[6-(4-Phenyl-2-thiazolylcarbamoyl)hexyl] thioisobutyrate S-(7-Oxo-7-((4-phenylthiazol-2-yl)amino)-heptyl) 2-methylpropanethioate 2-MethylpropanethioicacidS-[7-oxo-7-[(4-phenyl-2-thiazolyl)amino]heptyl]ester Propanethioic acid,2-methyl-, S-[7-oxo-7-[(4-phenyl-2-thiazolyl)amino]heptyl] ester |
CAS | 848354-66-5 |
化学式 | C20H26N2O2S2 |
分子量 | 390.56 |
密度 | 1.181±0.06 g/cm3(Predicted) |
熔点 | 127-128 °C(Solv: hexane (110-54-3); ethyl acetate (141-78-6)) |
溶解度 | DMSO: 可溶26mg/mL |
酸度系数 | 9.52±0.50(Predicted) |
存储条件 | 2-8°C |
外观 | 白色粉末 |
体外研究 | PTACH (compound 51) treatment elevates the levels of acetylated histone H4 and p21 WAF1/CIP1 in a dose-dependent manner. In cancer cell growth inhibition assay, PTACH (compound 51) shows strong activity. PTACH inhibits various cancer cells with EC50 values of 2.3 μM, 9.1 μM, 3.0 μM, 2.6 μM, 1.1 μM, 4.5 μM, 2.4 μM, 5.0 μM, and 4.5 μM for MDA-MB-231, SNB-78, HCT116, NCI-H226, LOX-IMVI, SK-OV-3, RXF-631L, St-4, and DU-145 cells, respectively. PTACH (NCH-51) augments the HIV-1 production in latently infected OM10.1 cells and such reactivation is associated with a loss of HDAC1 occupancy and subsequent hyperacetylation of histones in nuc-1 at the HIV-1 promoter. Western Blot Analysis Cell Line: HCT 116 cells Concentration: 1 μM, 5 μM, 25 μM Incubation Time: 8 hours Result: Gave rise to elevated and dose-dependent levels of acetylated histone H4 and p21 WAF1/CIP1 . |
危险品标志 | Xi - 刺激性物品 |
风险术语 | 41 - 对眼睛有严重伤害。 |
安全术语 | S26 - 不慎与眼睛接触后,请立即用大量清水冲洗并征求医生意见。 S39 - 戴护目镜或面具。 |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.56 ml | 12.802 ml | 25.604 ml |
5 mM | 0.512 ml | 2.56 ml | 5.121 ml |
10 mM | 0.256 ml | 1.28 ml | 2.56 ml |
5 mM | 0.051 ml | 0.256 ml | 0.512 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!